D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| 1 |
Alibaba
BABA
|
+$655M |
| 2 |
NVIDIA
NVDA
|
+$579M |
| 3 |
Amazon
AMZN
|
+$425M |
| 4 |
ConocoPhillips
COP
|
+$423M |
| 5 |
Johnson & Johnson
JNJ
|
+$380M |
Top Sells
| 1 |
Qualcomm
QCOM
|
+$868M |
| 2 |
Meta Platforms (Facebook)
META
|
+$554M |
| 3 |
Apple
AAPL
|
+$461M |
| 4 |
CELG
Celgene Corp
CELG
|
+$339M |
| 5 |
Pfizer
PFE
|
+$316M |
Sector Composition
| 1 | Technology | 19.2% |
| 2 | Consumer Discretionary | 16.83% |
| 3 | Healthcare | 16.01% |
| 4 | Industrials | 8.99% |
| 5 | Financials | 8.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
251
Nu Skin
NUS
$570M
| $59.8M | 0.07% |
1,211,867
+498,564
| +70% | +$24.6M |
|
252
Encompass Health
EHC
$12.7B
| $58.1M | 0.07% |
1,151,880
+11,525
| +1% | +$581K |
|
253
RingCentral
RNG
$2.94B
| $58M | 0.07% |
504,893
-14,006
| -3% | -$1.61M |
|
254
Stryker
SYK
$150B
| $57.9M | 0.07% |
281,447
+244,916
| +670% | +$50.3M |
|
|
XLNX
255
DELISTED
Xilinx Inc
XLNX
| $57.8M | 0.07% |
490,213
+270,386
| +123% | +$31.9M |
|
256
Chevron
CVX
$310B
| $57.8M | 0.07% |
464,090
-135,938
| -23% | -$16.9M |
|
257
Icon
ICLR
$13.8B
| $57.3M | 0.07% |
372,219
+25,723
| +7% | +$3.96M |
|
258
Insmed
INSM
$31B
| $56.8M | 0.07% |
2,218,947
+1,625,381
| +274% | +$41.6M |
|
259
Stanley Black & Decker
SWK
$12.1B
| $56.6M | 0.07% |
391,476
+374,617
| +2,222% | +$54.2M |
|
260
F5
FFIV
$18.4B
| $56.4M | 0.07% |
387,289
-42,053
| -10% | -$6.12M |
|
261
Healthpeak Properties
DOC
$12.7B
| $55.8M | 0.07% |
1,746,343
-369,721
| -17% | -$11.8M |
|
262
InterDigital
IDCC
$7.74B
| $55.8M | 0.07% |
867,162
+201,100
| +30% | +$13M |
|
263
Middleby
MIDD
$7.19B
| $55.8M | 0.07% |
411,432
+42,620
| +12% | +$5.78M |
|
264
Philip Morris
PM
$253B
| $55.5M | 0.07% |
707,222
+89,664
| +15% | +$7.04M |
|
265
UnitedHealth
UNH
$290B
| $55.2M | 0.07% |
226,089
+138,981
| +160% | +$33.9M |
|
266
Openlane
KAR
$3.11B
| $55M | 0.07% |
2,201,398
-6,357,292
| -74% | -$159M |
|
267
ASML
ASML
$313B
| $54.9M | 0.07% |
263,994
+50,024
| +23% | +$10.4M |
|
268
Alphabet (Google) Class C
GOOG
$2.83T
| $54.6M | 0.07% |
1,009,920
-1,993,260
| -66% | -$108M |
|
269
Arch Capital
ACGL
$33.9B
| $54.5M | 0.07% |
1,470,237
-146,070
| -9% | -$5.42M |
|
270
Brown-Forman Class B
BF.B
$13B
| $54.4M | 0.07% |
981,899
+863,186
| +727% | +$47.8M |
|
271
Pacira BioSciences
PCRX
$1.2B
| $54.3M | 0.07% |
1,248,573
+306,129
| +32% | +$13.3M |
|
|
AMED
272
DELISTED
Amedisys
AMED
| $54.3M | 0.07% |
446,941
+76,403
| +21% | +$9.28M |
|
273
Ametek
AME
$43.6B
| $54.2M | 0.07% |
596,129
+68,872
| +13% | +$6.26M |
|
274
M&T Bank
MTB
$31.1B
| $54.1M | 0.07% |
318,212
-161,656
| -34% | -$27.5M |
|
275
Voya Financial
VOYA
$7.3B
| $53.8M | 0.07% |
972,384
+130,108
| +15% | +$7.19M |
|